Jim Cramer Blog

Discuss Hot Stocks, Jim Cramer, Mad Money,the Stock and Option Markets, and the economy on Jim Cramer Blog.

Sunday, October 28, 2007

Merck & Co. Inc. (MRK) Shares Likely to Rise: Barron's

Merck & Co. Inc. (NYSE:MRK - News) shares could rise to $70 by 2010 if the drugmaker continues to deliver on its promise of double-digit earnings growth, Barron's said in its October 29 edition.
Merck's earnings could hit $4 per share by 2010, the magazine said. It added that Morgan Stanley analyst Jami Rubin, who rates Merck shares overweight, thinks it might reach that level a year sooner.
Applying its current multiple of 17.5 times prospective earnings to $4 a share would put the stock at $70, a 23 percent premium to its current share price of about $57, the magazine said.

Labels: , ,

Sunday, August 19, 2007

Barron's Debunks Jim Cramer

Shorting Cramer
Summary: After analyzing infamous TV stock-picker Jim Cramer's picks using all available means, Barron's says the only way to make more money off his picks than buying a simple index fund or ETF is to short a stock's 'pop' the day after a Cramer mention. Based on YourMoneyWatch.com, a website run by a retired stock analyst and Cramer fan, Cramer's picks consistently underperformed the market, making 12% over the past two years (before commissions) -- vs. 22% for the Dow and 16% for the S&P 500. A database of Cramer's Mad Money picks maintained by his website (http://MadMoney.TheStreet.com) which covers picks over the last six months were flat to down compared to the broad market. It also showed no performance difference between Cramer's Lightening Round picks (in which he judges stocks mentioned by callers with no advanced notice) and his pre-prepared Mad Money picks, despite his insistence to the contrary.CNBC, which airs Mad Money, told Barron's it was looking at the data incorrectly -- and that viewers should buy only the show's picks a week later. In an erroneous analysis, they say that Cramer's 'most-researched' stocks (about 12 a week) would have beaten the S&P by 0.8% over one month and 1.7% over two. The truth: They beat by 0.4% and 1.2% respectively, and fall short by 2.2% YTD. Barron's also questions how viewers are to know exactly which picks they should trade. His show's popularity, though, have been kind to Cramer's website, TheStreet.com: traffic, ad sales and shares have risen since Mad Money's 2005 launch, even as Cramer has sold off $4.6 million of his stake. When contacted by Barron's editor Bill Alpert, Cramer was belligerent. "I can show exact data, which says my picks are much better than the S&P," he insisted. Alpert spent weeks pursuing the not-forthcoming data.Published by Bill Alpert at SeekingAlpha

Labels: , ,

Sunday, April 01, 2007

Wyeth (WYE) Sees Huge Potential

Wyeth (NYSE:WYE - news) shares may rise 20 percent or more because its business is improving, its experimental drugs to treat patients with Alzheimer's disease are promising, and it could be an attractive takeover target, Barron's newspaper said in its April 2 edition.
The company's shares could rise into the 60s from Friday's close of $50.03, where the ratio of price to expected 2007 profit is 15 percent below typical peers among big drug companies, the newspaper said.
Wyeth shares trade at 14.5 times the average analyst forecast for $3.45 profit per share in 2007, according to Reuters Estimates. Fourth-quarter profit totaled $855 million, or 63 cents per share, and excluding items totaled 66 cents per share.
Barron's said Madison, New Jersey-based Wyeth should increase profit at 15 percent annually, regardless of whether any of its dozen Alzheimer's drugs under development pay off.
But it said if only a few of the drugs succeed, the company could generate hefty revenue should many of the 5 million Alzheimer's patients in the United States spend a few thousand dollars a year on treatments for the disease.
The newspaper said Enbrel, a product designed to treat arthritis, and Prevnar, a strep vaccine, should help lift cash flow and profit.
Another big product is the antidepressant Effexor, which generated about 18 percent of the fourth quarter's $5.22 billion of revenue.
The newspaper said Wyeth may also be near the end of incurring costs for its discontinued fen-phen diet drug, following a nationwide settlement and $21 billion of charges.
In addition, the newspaper said Wyeth is one of only a handful of drug companies that might be attractive merger partners for big rivals such as Pfizer Inc. (NYSE:PFE - news) and Switzerland's Novartis AG (NOVN.VX).
Wyeth's stock peaked at $70.25 in April 1999. Its shares' 52-week high is $54.10, set on October 19, 2006.
Published by SeekingAlpha

Labels: , , ,

Hewlett Packard (HPQ) Is the New Number 1 by Barron's

In less than two years, CEO Todd Bradley has turned Hewlett-Packard (NYSE: HPQ - News) into the top PC maker in the worldą„¤ A unit that once dragged earnings down, the company's PC division now accounts for about one third of total revenues. Cost cutting and higher quality production are responsible for improved PC margins, which climbed from break-even in FY 2003 to almost 4% in FY 2006. Strong overseas sales account for much of HP's revenue growth, as demand for pricey notebook computers is strong in such countries as India, where HP is the top selling brand. Within the U.S., HP maintains a larger slice of the consumer market than competitors, including Dell (NasdaqGS: DELL), which only operates domestically. HP's distribution method of selling from third party stores, once considered a cost disadvantage, has proven wise in the sale of notebook computers, as consumers want to get a first hand feel of the hardware they're buying.
Published by SeekingAlpha

Labels: , , ,

Walter Industries (WLT) Sees Light Ahead By Barron's

Production problems caused a tumble in the shares of small coal producer Walter (NYSE: WLT - News), falling 30% since last April to a recent $25. Those problems have since been fixed, and the company is expected to produce up to seven million tons of coal in 2007, lifting profits to $3.06 a share. Strong demand for Walter's main product, metallurgical coal, which sells for twice the price of regular coal, has analysts suggesting that earnings could rise 15% in the next five years. The company is meeting the demand with expanded capacity and has up to 20 years of reserves of the pricey product. Bulls also believe that a spinoff of Walter's home building and financing operations, profitable though they are, could help the company realize even greater value. Bottom Line: "The company's assets could be worth as much as 38 a share, 52% above its current stock price."
Published by SeekingAlpha

Labels: , ,

Monday, February 12, 2007

Barron's Says Novo Nordisk (NVO) is Set to Conquer Insulin Market

Summary: Novo Nordisk (NYSE: NVO - News) is the world sales leader of insulin-related products. Its insulin-analog products are bio-variants of the human insulin molecule that work better, are more bioavailable, sell for twice the price, and enjoy extended patent protection. Together with competitors Eli Lilly and Company (NYSE: LLY - News) and sanofi-aventis (NYSE: SNY - News), they have converted about 1/2 of all insulin-using patients to make the switch -- and Novo's product is the most complete and convenient. Its 2006 insulin analog sales jumped 50%, driving EPS was up 12% and giving it a P/E ratio of 26. Can the company continue to merit such a lofty multiple? Tech trader Bill Alpert says yes. Diabetes 'growth' is widespread; China accounted for over 40% of its international growth last year (though the U.S. government has been slow in accommodating 'biosimilar generics'). The company has other growth opportunities: It has a Phase III drug similar to but better than Amylin Pharmaceuticals Inc.'s (NasdaqGS: AMLN) Byetta (sold by Lilly) because Novo's version is taken once daily vs. Byetta's twice. And its hemophilia drug NovoSeven promises to reduce severe bleeding in trauma patients and during heart surgery, and may prove to be the first drug to address bleeding strokes.
Published by SeekingAlpha

Labels: , , , ,

Monday, December 25, 2006

Barron's Cover Story Summary

Summary: Bears worry an impending recession lies ahead, driven by overleveraged consumers burned by a collapse in home prices, and a huge current-account deficit that bespeaks our lust for consuming more than we produce and spending more than we save. But according to GaveKal, an international research boutique and respected advisor to some of the world's largest companies, the consumer is healthy, the U.S. economy stable, a housing crash improbable, and U.S. stocks are dramatically underpriced despite their current levels. The global economy, it asserts, is on the threshold of a decades-long deflationary boom that will lift America and much of the world to unprecedented prosperity. Its optimism stems from a theory that profound economic changes have and are taking place that have been ignored by most commentators -- specifically a business model it calls the "platform company." Its characteristics:
The platform company outsources low-return, volatile portions of its operations to low-cost manufacturers at home and abroad, focusing its resources instead on value-adding ventures such as R&D. This model seems to be behind the current surge in U.S. corporate profitability: Platform companies have reduced capital-spending needs, which also allows them to slash their debt-service burdens.
For platform companies R&D now dwarfs capital spending: This year the U.S. will spend about $330b on research and development, versus China's $136b. This global change is an "unalloyed good" according to GaveKal: productivity is enhanced, and intellectual property/knowledge is pursued to earn the higher returns that accompany breakthrough products and technologies.
GaveKal is not moved by America's growing account deficit, currently 7% of its GDP: U.S. household net worth stands at $54 trillion and growing at about $3t a year -- far larger and far faster than the $2.5 trillion it owes the rest of the world. Furthermore, trade statistics measure dollars, not profits per sale: The sale in the U.S. of a $700 computer might generate a negative trade balance of $450, because of components from Asian vendors shipped for assembly in the U.S. But the transaction might generate only a $30 profit for the Asian vendors, while high-margin American beneficiaries -- say a Dell system, with Microsoft software and an Intel microprocessor -- might realize a profit of about $250; the U.S. comes out a big winner even though the trade balance says it lost.
It's little wonder that foreigners are willing to finance our trade deficit: America boasts cutting-edge technology, high-margin companies, enviable productivity growth, liquid markets, political stability and strong private-property protection.
A housing market collapse is unlikely; real housing price growth in Ireland, the U.K., Spain, Sweden, France, Australia and the Netherlands have all outpaced that of the U.S. over the past 8 years, and seem none the worse. Barron's: "Optimism is often a tougher sell than bearishness. But based on the trends of the past half-century, GaveKal's argument looks like one worth buying."Highlighted companies: The following companies are cited in the article as being platform companies: Apple Computer Inc. (NASDAQ: AAPL - News), Motorola Inc. (NYSE: MOT - News), Hewlett-Packard Co. (NYSE: HPQ - News), Dell Inc. (NASDAQ: DELL - News), Black & Decker Corp. (NYSE: BDK - News), International Business Machines Corp. (NYSE: IBM - News), Danaher Corp. (NYSE: DHR - News), and Analog Devices Inc. (NYSE: ADI - News)
-SeekingAlpha

Labels: , , , , , , , ,

Sunday, December 17, 2006

TurboChef Technologies Inc. (OVEN) Stock Could Rise in 2007

TurboChef Technologies Inc. (OVEN.OQ: Quote, Profile , Research), a maker of speed-cooking ovens, could see its shares rise 40 percent in the next year and may ultimately be acquired by a major appliance maker, according to a report in Barron's. Two money managers think General Electric Co. (GE.N: Quote, Profile , Research), Whirlpool Corp. (WHR.N: Quote, Profile , Research), Germany's Miele or Sweden's Electrolux (ELUXb.ST: Quote, Profile , Research) might want to buy it, the weekly business newspaper said in its December 18 edition. The stock remains highly speculative, with some 25 percent of the outstanding publicly available shares having been sold short, as those investors bet the stock price will drop, Barron's said. But they may be underestimating the company's potential, the paper said, noting that coffee retailer Starbucks Corp. (SBUX.O: Quote, Profile , Research). could be a big buyer of TurboChef's products, and Dunkin' Brands may start ramping up installations.
Source: Reuters.com

Labels: , , , , ,

Brinks Co. (BCO) May Get More Pressure to Sell Says Barron's

U.S. security company Brink's Co. (NYSE:BCO - News) may this week be urged by yet another major investor to sell part or all of itself, according to Barron's.
Millbrook Capital Management, a New York hedge fund that controls 8.3 percent of outstanding Brink's shares, will join the ranks of investors who want Brink's to consider a sale, the financial newspaper said in its December 18 issue.
Activist hedge fund Pirate Capital said last month Brink's should explore a sale of the company, start a large Dutch tender offer for its shares, and immediately appoint Pirate founder Thomas Hudson to its board.
Millbrook's proposal is expected to be outlined in a regulatory update of stock-ownership disclosure, the paper said. By Millbrook's estimates, buyout firms could pay $70 to $73 a share and still generate a 22.5 percent internal rate of return, the paper said. Brink's shares closed on Friday at $60.17 on the New York Stock Exchange.
Potential strategic buyers could include United Technologies Corp. (NYSE:UTX - News), General Electric Co. (NYSE:GE - News) and Siemens AG (XETRA:SIEGN.DE - News), Barron's said, citing analysts. Those suitors could pay from $70 to $81 for a quickly accretive deal.
-Reuters

Labels: , , , ,

Barron's Cover: ConocoPhillips (COP)

Highlighted companies: ConocoPhillips (NYSE: COP - News), ExxonMobil Corp. (NYSE: XOM - News), Chevron Corp. (NYSE: CVX - News), Berkshire Hathaway Inc. , E.I. DuPont de Nemours (NYSE: DD - News), EnCana Corp. (NYSE: ECA - News)Summary: Through shrewd acquisitions, ConocoPhillips (NYSE: COP - News) is now the third-biggest U.S. energy company behind ExxonMobil Corp. (NYSE: XOM - News) and Chevron Corp. (NYSE: CVX - News). COP shares were punished after its Dec. '05 $35b acquisition of Burlington Resources, which it acquired when natural-gas prices were double their current level. Barron's likes the company:
Its 7x P/E ratio is the lowest among all the DJ Global Titans (the 50 largest companies worldwide), making it "too cheap to ignore" according to Robert Marcin of Defiance Asset Management. Put in another way, investors currently pay only $9/barrel for each of the company's 10b barrels of reserves.
Respected shareholders include Berkshire Hathaway Inc. -- "one of the company's biggest fans," owning 18m shares and doubling its holding this year -- Davis Selected Advisers, Wellington Management, Dodge & Cox and Barrow Hanley.
Its rock-bottom P/E ratio and global asset base make it an attractive buyout target despite its massive $120b market cap.
The company recently announced it will exercise restraint with acquisitions and beef-up share repurchases.
Spun off from E.I. DuPont de Nemours (NYSE: DD - News) in 1998, COP was worth only $12b just seven years ago -- now it is North America's largest natural-gas producer and its second largest refiner. It built itself on purchases such as a 19% stake in Lukoil and buying Tosco, a major U.S. refiner. Morgan Stanley's Doug Terreson: "The record speaks for itself; [CEO Jim] Mulva has made a lot of out-of-consensus purchases that have substantially rewarded shareholders."
It received little credit for its Canadian oil sands position, which it strengthened in October reaching a deal with EnCana Corp. (NYSE: ECA - News) that gives COP half of ECA's enormous oil-sands reserves, which could yield 5-6 billion barrels of crude. Production, now 50k barrels daily, could hit 400,000-500,000 by 2015.
While some bears don't like that a high-percentage of its reserves are in mature fields, Mulva says critics are underestimating the technology available to extend the lives of older fields.
Source: Eli Hoffmann of SeekingAlpha

Labels: , ,

Sunday, November 26, 2006

Google Inc. (GOOG) Stock Set For a Fall According to Barron's

Google Inc. (NASDAQ:GOOG - News) shares, which topped a milestone price of $500 a share last week, are overvalued and poised to fall, just like peers Amazon.com Inc. (NASDAQ:AMZN - News) and eBay Inc. (NASDAQ:EBAY - News) did, the weekly financial newspaper Barron's reported on Sunday.
Barron's said Google is overvalued because it trades at 37 times next year's expected earnings and because its growth rate is slowing. It also noted that Google now has the 15th largest market capitalization among U.S.-traded shares, and its price-to-earnings ratio is two to three times higher that of similarly sized companies.
Analysts predicted a 33 percent gain in Google's earnings in 2007, versus the 81 percent increase the company is on track to produce this year, Barron's said.
The paper added that the price that advertisers are willing to pay for search keywords has fallen.

Labels: , , , ,

Sunday, November 12, 2006

Barron's Says New York Times Undervalued

Shares of the New York Times Co. (NYSE:NYT - News) may be undervalued despite strong properties and opportunities to boost margins, according to financial publication Barron's.
Based on discussions with two institutional investors, a Barron's analysis suggests that the company is worth about $35 a share. Shares of the company closed Friday at $23.99.
A challenge by Morgan Stanley Investment Management, which owns 7.6 percent of the stock, to the company's dual-share-class ownership structure could also pressure Chairman Arthur Sulzberger Jr. and CEO Janet Robinson to improve the company's financial performance, Barron's said.
Currently, class A shareholders elect four of the New York Times' 13 directors. The Sulzbergers hold class B shares, which represent less than 1 percent of the company's equity interests, but elect nine directors.
The Sulzbergers are descendants of Adolph Ochs, who bought the newspaper more than a century ago.
-Reuters

Labels: , ,

This site is not affiliated with Mr. James Cramer, and is not associated with any television networks or broadcasts. Data presented on this site should not be used to make investment decisions and accuracy cannot be guaranteed GRB Holding Co., LLC

;